MDxHealth (NASDAQ:MDXH) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of MDxHealth (NASDAQ:MDXH - Free Report) to a hold rating in a report issued on Saturday morning.

MDxHealth Stock Performance

MDxHealth stock traded up $0.08 during trading hours on Friday, hitting $2.12. 48,371 shares of the stock traded hands, compared to its average volume of 86,263. MDxHealth has a 1 year low of $1.35 and a 1 year high of $3.50. The firm's 50 day moving average price is $1.68 and its 200-day moving average price is $1.85. The company has a debt-to-equity ratio of 3.14, a current ratio of 1.54 and a quick ratio of 1.45. The stock has a market capitalization of $100.25 million, a price-to-earnings ratio of -1.39 and a beta of 1.32.

MDxHealth (NASDAQ:MDXH - Get Free Report) last posted its earnings results on Wednesday, May 14th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.06). MDxHealth had a negative net margin of 49.52% and a negative return on equity of 1,077.84%. The firm had revenue of $24.29 million during the quarter, compared to analyst estimates of $22.62 million. As a group, equities analysts expect that MDxHealth will post -1.15 EPS for the current fiscal year.

Institutional Investors Weigh In On MDxHealth

Several institutional investors have recently bought and sold shares of the company. AWM Investment Company Inc. boosted its position in MDxHealth by 10.6% during the first quarter. AWM Investment Company Inc. now owns 5,221,282 shares of the company's stock worth $7,414,000 after acquiring an additional 499,992 shares during the last quarter. Samjo Management LLC raised its position in MDxHealth by 130.9% in the fourth quarter. Samjo Management LLC now owns 1,824,312 shares of the company's stock valued at $4,324,000 after purchasing an additional 1,034,312 shares during the period. Perkins Capital Management Inc. boosted its holdings in MDxHealth by 20.1% during the 1st quarter. Perkins Capital Management Inc. now owns 1,181,475 shares of the company's stock valued at $1,678,000 after acquiring an additional 198,000 shares during the period. Northern Trust Corp acquired a new position in shares of MDxHealth in the fourth quarter valued at approximately $1,033,000. Finally, Delta Investment Management LLC increased its position in shares of MDxHealth by 459.1% during the first quarter. Delta Investment Management LLC now owns 190,100 shares of the company's stock worth $270,000 after acquiring an additional 156,100 shares during the period.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.